Call Us : 1.919.354.1053

News

New Developments

NIRvana Sciences Welcomes Lisa Cooper to Board of Directors

RESEARCH TRIANGLE PARK, NC, May, 2015 – NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins in the field of fluorescent dyes, announced that Lisa Cooper has joined the Board of Directors.  Lisa is owner and VP of PMI Ash and brings significant management and IP portfolio
READ MORE

NIRvana Sciences Wins 2nd NIH Phase I STTR

RESEARCH TRIANGLE PARK, NC, April 30th, 2015– NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins in the field of fluorescent dyes, today announced that it has been awarded a second $225k Phase I STTR from NIH’s National Institute of Biomedical Imaging and Bioengineering.
READ MORE

NIRvana Sciences Receives Notification of 25th Issued Patent

RESEARCH TRIANGLE PARK, NC, March 17th, 2015– NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins in the field of fluorescent dyes, today announced that it had been informed that the 25th patent in its exclusively licensed portfolio had been issued by the U.S. Patent and Trademark Office
READ MORE

NIRvana Sciences Establishes Conjugation Lab

RESEARCH TRIANGLE PARK, NC, July, 2014 – NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins in the field of fluorescent dyes, announced that it has set-up a dye conjugation lab and hired cell biologist, Rose Evans-Storms, to its team.
READ MORE